Browsing by Author Martin Alfons Gengenbacher

Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
2012Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisWarrier, T; Tropis, M; Werngren, J; Diehl, A; Gengenbacher, M ; Schlegel, B; Schade, M; Oschkinat, H; Daffe, M; Hoffner, S; Eddine, A.N; Kaufmann, S.H.E
2015Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencingRienksma, Rienk A.; Su�rez Diez, Mar�a; Mollenkopf, Hans Joachim; Dolganov, Gregory M.; Dorhoi, Anca; Schoolnik, Gary K.; Martins Dos Santos, V. A. P.; Kaufmann, Stefan H E; Schaap, Peter J.; Gengenbacher, Martin 
2016Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG ΔureC:: Hly improves protection against tuberculosisGengenbacher, M ; Nieuwenhuizen, N; Vogelzang, A; Liu, H; Kaiser, P; Schuerer, S; Lazar, D; Wagner, I; Mollenkopf, H.-J; Kaufmann, S.H.E
2016Developmental transcriptome of resting cell formation in Mycobacterium smegmatisWu M.-L. ; Gengenbacher M. ; Chung J.C.S. ; Chen S.L. ; Mollenkopf H.-J.; Kaufmann S.H.E.; Dick T. 
2017Draft genome sequence of Mycobacterium abscessus BambooYee, M ; Klinzing, D; Wei, J.-R; Gengenbacher, M ; Rubin, E.J; Dick, T 
2017Draft genome sequence of Mycobacterium avium 11Yee, M ; Klinzing, D; Wei, J.-R; Gengenbacher, M ; Rubin, E.J; Chien, J.-Y; Hsueh, P.-R; Dick, T 
2018Impact of immunopathology on the antituberculous activity of pyrazinamideBlanc, L; Sarathy, J.P; Cabrera, N.A; O’Brien, P; Dias Freedman, I; Mina, M; Sacchettini, J; Savic, R.M; Gengenbacher, M ; Podell, B.K; Prideaux, B; Ioerger, T; Dick, T ; Dartois, V
2016Mild nutrient starvation triggers the development of a small-cell survival morphotype in mycobacteriaWu, M.-L ; Gengenbacher, M ; Dick, T 
2017NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humansGengenbacher, M ; Duque-Correa, M.A; Kaiser, P; Schuerer, S; Lazar, D; Zedler, U; Reece, S.T; Nayyar, A; Cole, S.T; Makarov, V; Barry, C.E; Dartois, V; Kaufmann, S.H.E
2016Pyrazinamide resistance is caused by two distinct mechanisms: Prevention of coenzyme a depletion and loss of virulence factor synthesisGopal, P ; Yee, M; Sarathy, J ; Liang Low, J ; Sarathy, J.P; Kaya, F; Dartois, V; Gengenbacher, M ; Dick, T 
2017Rifabutin Is active against mycobacterium abscessus complexAziz, D.B ; Low, J.L ; Wu, M.-L ; Gengenbacher, M ; Teo, J.W.P; Dartois, V; Dick, T 
2018The mycobacterial membrane: A novel target space for anti-tubercular drugsChen H. ; Nyantakyi S.A.; Li M.; Gopal P. ; Aziz D.B. ; Yang T. ; Moreira W. ; Gengenbacher M. ; Dick T. ; Go M.L. 
2013The tuberculosis vaccine candidate bacillus Calmette-Guérin ?ureCRao M.; Vogelzang A.; Kaiser P.; Schuerer S.; Kaufmann S.H.E.; Gengenbacher M. 
2018Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercularNegatu, D.A; Liu, J.J.J; Zimmerman, M; Kaya, F; Dartois, V; Aldrich, C.C; Gengenbacher, M ; Dicka, T